Traders Buy High Volume of Amedisys Put Options (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) was the target of unusually large options trading activity on Friday. Investors bought 3,269 put options on the stock. This represents an increase of approximately 136% compared to the average daily volume of 1,385 put options.

Amedisys Trading Up 4.7 %

Amedisys stock opened at $89.96 on Friday. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 35.70, a P/E/G ratio of 1.84 and a beta of 0.73. The firm has a 50-day moving average of $90.45 and a 200-day moving average of $94.43. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys has a one year low of $82.15 and a one year high of $98.95.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. During the same period last year, the company posted $0.98 earnings per share. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. On average, equities analysts expect that Amedisys will post 4.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Institutional investors have recently added to or reduced their stakes in the company. National Bank of Canada FI lifted its stake in Amedisys by 119.0% in the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider’s stock valued at $5,365,000 after acquiring an additional 30,213 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after purchasing an additional 19,660 shares during the last quarter. Geode Capital Management LLC lifted its stake in Amedisys by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock valued at $54,746,000 after purchasing an additional 7,071 shares during the last quarter. Quarry LP bought a new position in Amedisys during the third quarter worth about $2,569,000. Finally, Charles Schwab Investment Management Inc. increased its position in Amedisys by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock worth $33,400,000 after buying an additional 9,004 shares during the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.